Marketing-authorisation holder · Brazil
Beaufour Ipsen Farmacêutica Ltda
7 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BYLVAY | Odevixibat | Brazil | Authorised | 2023 |
| CABOMETYX | Levomalato cabozantinibe | Brazil | Authorised | 2018 |
| DYSPORT | Toxina botulínica a | Brazil | Authorised | 2009 |
| IQIRVO | Elafibranor | Brazil | Authorised | 2025 |
| SOMATULINE AUTOGEL | Lanreotide | Brazil | Authorised | 2009 |
| Mevatyl | Tetraidrocanabinol, Cannabidiol | Brazil | Cancelled | 2017 |
| TAZVERIK | Tazemetostat | Brazil | Cancelled | 2025 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current |
|---|